Colgate-Palmolive Co

Colgate-Palmolive Co(CL)股票分析

$92.780

+2.923 (+3.15%)收盤時

Loading chart…
最高
92.870
開盤
90.630
成交量加權均價
92.09
成交量
5.39M
市值
80.54B
最低
90.630
成交金額
495.92M
企業價值/稅息折舊攤銷前利潤(TTM)
14.84

Colgate-Palmolive Company is a growth company. It is focused on Oral Care, Personal Care, Home Care and Pet Nutrition, it sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Its Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. Its Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and e-commerce retailers.

AI 分析 of Colgate-Palmolive Co (CL)

持有

Colgate-Palmolive Co is currently priced at $88.27, with a forward P/E of 20.96, indicating reasonable valuation compared to its earnings potential. However, the RSI is at 70.76, suggesting it may be overbought in the short term. The company has a strong gross margin of 61.48%, which supports its profitability. The main risk is the insider selling activity, which has increased by 20884.53% over the last month, indicating potential concerns among insiders about the company's future performance.

分析師評級(23)

-5.38% 下跌空間
持有
5 買進
17 持有
1 賣出
目前: 92.78
最低
77.00
平均
87.79
最高
95.00

BofA

2026-10-09

目標價

$100

買進

Piper Sandler

2026-09-21

目標價

$95

增持

Deutsche Bank

2026-08-03

目標價

$101

買進

RBC Capital

2026-08-03

目標價

$104

優於大盤

TD Cowen

2026-08-03

目標價

$90

持有

估值指標

Colgate-Palmolive Co(CL)目前預期本益比為 20.96,5 年平均預期本益比為 23.95。

預期本益比

低估
5 年均值 P/E
23.95
目前P/E
20.96
高估
25.96
低估
21.95

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
15.83
目前EV/EBITDA
14.84
高估
17.03
低估
14.64

預期股價營收比

合理
5 年均值 P/S
3.46
目前P/S
3.25
高估
3.76
低估
3.16

Alphio AI 對 CL 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%CL

$102.10

情境價格

基

基準

基準 · 50%CL

$94.63

情境價格

悲

悲觀

悲觀 · 25%CL

$90.11

情境價格

持有 CL 的大戶

I

INTECH Investment Management LLC

+ 持有CL

+7.79%

3個月報酬率

D

Diversified Trust Company, Inc.

+ 持有CL

+7.24%

3個月報酬率

B

Bank J. Safra Sarasin AG

+ 持有CL

+7.11%

3個月報酬率

A

AG2R LA MONDIALE GESTION d'ACTIFS

+ 持有CL

+6.41%

3個月報酬率

Y

Yacktman Asset Management LP

+ 持有CL

+5.83%

3個月報酬率

E

E. Öhman J:or Wealth Management

+ 持有CL

+5.76%

3個月報酬率

事件時間軸

2026-09-11 (ET)

16:30:00

Major Averages Surge as Inflation Pressure Eases

12:00:00

Major Averages Rebound as Oil Prices Retreat

2026-07-31 (ET)

16:30:00

Apple Plummets Post-Earnings, Amazon Reports Strong Results

12:30:00

Apple Shares Face Worst Post-Earnings Drop in 13 Years, $460B Wipeout

資訊

CL 常見問題 —— 由 Alphio AI 解答

Colgate-Palmolive Company is a growth company. It is focused on Oral Care, Personal Care, Home Care and Pet Nutrition, it sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Its Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. Its Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and e-commerce retailers. It operates in the Consumer Non-Cyclicals sector (PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS industry).

Colgate-Palmolive Co is currently priced at $88.27, with a forward P/E of 20.96, indicating reasonable valuation compared to its earnings potential. However, the RSI is at 70.76, suggesting it may be overbought in the short term. The company has a strong gross margin of 61.48%, which supports its profitability. The main risk is the insider selling activity, which has increased by 20884.53% over the last month, indicating potential concerns among insiders about the company's future performance.

23 analysts cover CL: 5 rate it Buy, 17 Hold and 1 Sell. The average price target is 87.79.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易